TY - JOUR
T1 - Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T-cell activation and dendritic cell maturation
AU - Oliva, Harold
AU - Pacheco, Rodrigo
AU - Martinez-Navio, José M.
AU - Rodríguez-García, Marta
AU - Naranjo-Gómez, Mar
AU - Climent, Núria
AU - Prado, Carolina
AU - Gil, Cristina
AU - Plana, Montserrat
AU - García, Felipe
AU - Miró, José M.
AU - Franco, Rafael
AU - Borras, Francesc E.
AU - Navaratnam, Naveenan
AU - Gatell, José M.
AU - Gallart, Teresa
N1 - Publisher Copyright:
© 2016 Australasian Society for Immunology Inc. All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G; A3G) is an innate defense protein showing activity against retroviruses and retrotransposons. Activated CD4+ T cells are highly permissive for HIV-1 replication, whereas resting CD4+ T cells are refractory. Dendritic cells (DCs), especially mature DCs, are also refractory. We investigated whether these differences could be related to a differential A3G expression and/or subcellular distribution. We found that A3G mRNA and protein expression is very low in resting CD4+ T cells and immature DCs, but increases strongly following T-cell activation and DC maturation. The Apo-7 anti-A3G monoclonal antibody (mAb), which was specifically developed, confirmed these differences at the protein level and disclosed that A3G is mainly cytoplasmic in resting CD4+ T cells and immature DCs. Nevertheless, A3G translocates to the nucleus in activated-proliferating CD4+ T cells, yet remaining cytoplasmic in matured DCs, a finding confirmed by immunoblotting analysis of cytoplasmic and nuclear fractions. Apo-7 mAb was able to immunoprecipitate endogenous A3G allowing to detect complexes with numerous proteins in activated-proliferating but not in resting CD4+ T cells. The results show for the first time the nuclear translocation of A3G in activated-proliferating CD4+ T cells.
AB - APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G; A3G) is an innate defense protein showing activity against retroviruses and retrotransposons. Activated CD4+ T cells are highly permissive for HIV-1 replication, whereas resting CD4+ T cells are refractory. Dendritic cells (DCs), especially mature DCs, are also refractory. We investigated whether these differences could be related to a differential A3G expression and/or subcellular distribution. We found that A3G mRNA and protein expression is very low in resting CD4+ T cells and immature DCs, but increases strongly following T-cell activation and DC maturation. The Apo-7 anti-A3G monoclonal antibody (mAb), which was specifically developed, confirmed these differences at the protein level and disclosed that A3G is mainly cytoplasmic in resting CD4+ T cells and immature DCs. Nevertheless, A3G translocates to the nucleus in activated-proliferating CD4+ T cells, yet remaining cytoplasmic in matured DCs, a finding confirmed by immunoblotting analysis of cytoplasmic and nuclear fractions. Apo-7 mAb was able to immunoprecipitate endogenous A3G allowing to detect complexes with numerous proteins in activated-proliferating but not in resting CD4+ T cells. The results show for the first time the nuclear translocation of A3G in activated-proliferating CD4+ T cells.
UR - http://www.scopus.com/inward/record.url?scp=84963596200&partnerID=8YFLogxK
U2 - 10.1038/icb.2016.28
DO - 10.1038/icb.2016.28
M3 - Article
C2 - 26987686
AN - SCOPUS:84963596200
SN - 0818-9641
VL - 94
SP - 689
EP - 700
JO - Immunology and Cell Biology
JF - Immunology and Cell Biology
IS - 7
ER -